세계의 해동 시스템 시장(국가별 시장 포함)

Global Thawing Systems Market to Reach US$564.5 Million by 2030

The global market for Thawing Systems estimated at US$297.1 Million in the year 2024, is expected to reach US$564.5 Million by 2030, growing at a CAGR of 11.3% over the analysis period 2024-2030. Blood, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$287.7 Million by the end of the analysis period. Growth in the Embryo segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.7 Million While China is Forecast to Grow at 10.4% CAGR

The Thawing Systems market in the U.S. is estimated at US$80.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$85.7 Million by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.9% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Thawing Systems Market - Key Trends and Drivers Summarized

Why Are Thawing Systems Gaining Traction in the Biopharmaceutical Industry?

Thawing systems have become essential in the biopharmaceutical and healthcare sectors due to their pivotal role in the controlled thawing of biological samples such as plasma, blood, vaccines, and tissues. These systems ensure that sensitive biological products are thawed without compromising their quality and efficacy. With the rise of biologics and cell-based therapies, the need for advanced, precise, and automated thawing technologies has grown significantly. In recent years, there has been an increasing trend toward the adoption of programmable thawing systems that offer real-time monitoring, ensuring consistent thawing processes. This surge in demand is also driven by the expanding cell therapy market and the growing emphasis on maintaining cold chain integrity for biologics, especially in clinical trials and research settings.

How Are Different Segments and End-Use Markets Shaping Thawing Systems?

The market for thawing systems is categorized by product types such as manual, automated, and benchtop systems, which cater to different applications and scales of use. Automated thawing systems, for instance, have seen increased adoption in biopharmaceutical manufacturing and research laboratories, where they are used for the large-scale thawing of samples. The end-user segments are primarily composed of hospitals, diagnostic laboratories, biotechnology firms, and research institutions. In the hospital segment, thawing systems are crucial for preparing blood and plasma for transfusions, while in research labs, these systems are essential for processing frozen cells and tissues. Additionally, the growing use of thawing systems in fertility clinics and cord blood banks is also contributing to the market’s expansion.

What Emerging Trends Are Transforming the Thawing Systems Market?

Recent innovations in the thawing systems market have focused on improving efficiency, precision, and automation. For instance, there is a rising trend toward developing systems that can handle a broad range of sample volumes while offering programmable features for customized thawing protocols. The growing integration of advanced sensors and data management solutions has transformed these systems into critical tools for ensuring compliance with regulatory standards, particularly in the storage and handling of biologics. Another notable trend is the increased use of single-use thawing bags that minimize contamination risks and offer greater operational convenience. Furthermore, as demand for personalized medicine and advanced cell therapies continues to rise, thawing systems are evolving to meet the complex needs of these growing fields.

What Factors Are Driving the Growth of the Thawing Systems Market?

The growth in the thawing systems market is driven by several factors, including the rising demand for biopharmaceuticals, the increasing prevalence of chronic diseases requiring advanced therapies, and the expansion of the biologics manufacturing sector. With biopharmaceutical companies investing heavily in research and development for cell and gene therapies, there is a pressing need for precise thawing solutions. Moreover, regulatory agencies are setting higher standards for the handling of biological materials, which is fueling the demand for compliant thawing technologies. The growing emphasis on maintaining cold chain integrity, particularly in the wake of large-scale vaccine distribution efforts, is also contributing to market growth. Finally, the development of automated and energy-efficient thawing systems, which reduce operational costs and enhance productivity, is further driving the market’s expansion.

SCOPE OF STUDY:

The report analyzes the Thawing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sample Type (Blood, Embryo, Ovum, Semen); End-Use (Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Barkey GmbH & Co. KG
• Biocision, LLC
• Boekel Scientific, Inc.
• Cardinal Health, Inc.
• CytoTherm
• GE Healthcare
• Helmer Scientific
• Sarstedt AG & Co.
• Sartorius AG
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Thawing Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in Automated Thawing Technologies Propel Growth of Thawing Systems Market
  • Rising Adoption of Biopharmaceuticals Spurs Demand for Efficient Thawing Solutions
  • Increased Focus on Cold Chain Logistics Expands Addressable Market Opportunity
  • Growing Investment in Cell and Gene Therapy Strengthens Business Case for Thawing Systems
  • Emergence of Rapid Thawing Techniques Accelerates Demand for Innovative Thawing Systems
  • Rising Focus on Sample Integrity in Clinical Labs Spurs Need for Advanced Thawing Solutions
  • Increased Utilization of Frozen Stem Cells and Tissues Propels Market for Thawing Systems
  • Technological Innovations in Cryopreservation Fuel Market Growth for Efficient Thawing
  • Growing Number of Biobanks and Biorepositories Expands Demand for Automated Thawing Systems
  • Increasing Emphasis on Sustainability Spurs Development of Energy-efficient Thawing Systems
  • Growing Adoption of Single-use Technologies in Bioprocessing Accelerates Thawing Systems Market
  • Expansion of Biopharmaceutical Manufacturing Capabilities Boosts Demand for Thawing Equipment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Thawing Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Embryo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Embryo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ovum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Ovum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Semen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Semen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Tissue Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Tissue Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 19: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 22: USA Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 23: USA 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 24: USA Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 25: USA 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Canada 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 28: Canada Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 29: Canada 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• JAPAN
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 30: Japan Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 31: Japan 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Japan 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• CHINA
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 34: China Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 35: China 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 36: China Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 37: China 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• EUROPE
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: Europe 6-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 40: Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 41: Europe 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 42: Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Europe 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• FRANCE
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 44: France Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: France 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 46: France Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 47: France 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• GERMANY
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 48: Germany Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Germany 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 50: Germany Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Germany 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• ITALY
  • TABLE 52: Italy Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Italy 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 54: Italy Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Italy 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• UNITED KINGDOM
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 56: UK Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: UK 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 58: UK Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 59: UK 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Rest of Europe 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Rest of Europe 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• ASIA-PACIFIC
  • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Asia-Pacific 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 67: Asia-Pacific 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Rest of World 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
  • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 71: Rest of World 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION